Idiopathic Hypersomnia
📧 Sign up to get email alerts when something new happens for Idiopathic Hypersomnia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-27Clinical Trial Results: A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy [Phase 4]
Phase 4 trial investigating the effect of XYWAV on sleepiness, polysomnography, and functional outcomes in idiopathic hypersomnia and narcol…
-
CLINICAL_TRIALS trial_result · 2026-08-07Clinical Trial Results: Clarithromycin Mechanisms in Hypersomnia Syndromes [Phase 2]
Phase 2 trial results on clarithromycin mechanisms in hypersomnia syndromes including narcolepsy without cataplexy and idiopathic hypersomni…
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: Study of SDX in Patients With Idiopathic Hypersomnia (IH) [Phase 2]
Phase 2 trial results for SDX in idiopathic hypersomnia have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Improving Social Relationships for Adolescents With Central Disorders of Hypersomnolence [NA]
This document reports the completion of a clinical trial evaluating interventions to improve social relationships for adolescents with centr…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ) [Phase 3]
Phase 3 clinical trial update evaluating the safety and efficacy of FT218 for idiopathic hypersomnia, sponsored by Avadel under the REVITALY…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia [Phase 3]
A completed Phase 3 long-term study assessing the safety and effectiveness of pitolisant in adult patients with idiopathic hypersomnia, incl…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy [Phase 4]
A Phase 4 study evaluating XYWAV for sleepiness, polysomnography metrics, and functional outcomes in idiopathic hypersomnia and narcolepsy h…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Clarithromycin Mechanisms in Hypersomnia Syndromes [Phase 2]
Phase 2 clinical trial examining clarithromycin mechanisms in hypersomnia syndromes has completed. The study enrolled individuals with narco…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH [Phase 2]
A Phase 2, placebo-controlled, double-blind trial evaluating the safety and efficacy of SDX in idiopathic hypersomnia has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia [Phase 3]
This clinical trial update notes the completion of a Phase 3 study evaluating pitolisant for safety and efficacy in adults with idiopathic h…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Efficacy and Tolerance of Solriamfetol in Patients Affected with Idiopathic Hypersomnia. [Phase 2]
Phase 2 trial evaluating the efficacy and tolerance of solriamfetol in idiopathic hypersomnia; the study is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia [Phase 2]
A Phase 2 trial comparing modafinil versus amphetamines for Narcolepsy Type 2 and Idiopathic Hypersomnia has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Sodium Oxybate in Idiopathic Hypersomnia [Phase 2, Phase 3]
A phase 2/3 clinical trial update for sodium oxybate in idiopathic hypersomnia has been completed, reporting results across two trial phases…
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia [Phase 1]
A Phase 1 trial assessing a single IV dose of TAK-925 in participants with idiopathic hypersomnia has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension [Phase 3]
Phase 3 multicenter trial evaluating the efficacy and safety of JZP-258 for Idiopathic Hypersomnia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia [Phase 2]
Phase 2 clinical trial update for oral BTD-001 in adults with idiopathic hypersomnia.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2 [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of BTD-001 in idiopathic hypersomnia and narcolepsy type 2 (narcolepsy without cataple…
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Cardiovascular Variability and Heart Rate Arousal Response in Idiopathic Hypersomnia
This clinical trial update notes the completion of a study evaluating cardiovascular variability and heart rate arousal response in idiopath…
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Clarithromycin for the Treatment of Hypersomnia [Phase 2]
A Phase 2 trial evaluating clarithromycin for hypersomnia disorders (hypersomnia, idiopathic hypersomnia, and narcolepsy) has completed with…
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: Flumazenil for the Treatment of Primary Hypersomnia [Phase 1, Phase 2]
Phase 1/2 clinical trial of flumazenil for primary hypersomnia completed with results posted in 2013.